Late Onset Pseudolymphomatous Reaction to Blue Tattoo Pigment Precipitated by Covid Vaccination
Main Article Content
Keywords
pseudolymphoma, tattoo ink, tattoo reaction, cutaneous reaction, pseudolymphomatous reaction
Abstract
Tattoos can lead to a variety of cutaneous conditions such as allergic or contact dermatitis, lichenoid dermatitis, pseudolymphomatous reactions and granulomatous responses such as foreign body granulomas that may have a sarcoidal histology simulating sarcoidosis.[1] Pseudolymphomatous reactions are less common and may clinically and histologically resemble cutaneous lymphomas. Pseudolymphomatous reactions may develop in response to injections, Borrelia infections and arthropod bites. Diagnosis of cutaneous pseudolymphoma is usually based on clinicopathologic correlation coupled with skin biopsy and ancillary tests such as immunoperoxidase stains and genetic testing when necessary. Treatment is generally successful with application of topical corticosteroid preparation or injection of intralesional corticosteroids and in some cases, surgical excision. Here, we describe the case of a 61-year-old male who presented with 3-4 mm papules contained within the blue region of a multicolored tattoo on his upper right arm that had been present for several years. The reaction developed shortly following a Covid vaccination.
References
2. Mitteldorf C, Kempf W. Cutaneous Pseudolymphoma. Surg Pathol Clin. 2017 Jun;10(2):455-476. doi: 10.1016/j.path.2017.01.002. Epub 2017 Mar 22. PMID: 28477891.American Academy of Dermatology. “Dermatologist warns consumers about complications linked to newer tattoo inks.” News release issued March 1, 2013. Last accessed July 20, 2018
3. Campolmi P, Bassi A, Bonan P, et al. Cutaneous pseudolymphoma localized to black tattoo. J Am Acad Dermatol. 2011;65(5):e155–7.
4. Amann U, Luger TA, Metze D. Lichenoid pseudolymphomatous tattooing reaction. Hautarzt Z Für Dermatol Venerol Verwandte Geb. 1997;48(6):410–3.
5. Kahofer P, El Shabrawi-Caelen L, Horn M, Kern T, Smolle J. Pseudolymphoma occurring in a tattoo. Eur J Dermatol. 2003 Mar-Apr;13(2):209-12. PMID: 12695144.
6. Gutermuth J, Hein R, Fend F, Ring J, Jakob T. Cutaneous pseudolymphoma arising after tattoo placement. J Eur Acad Dermatol Venereol. 2007 Apr;21(4):566-7. doi: 10.1111/j.1468-3083.2006.01964.x. PMID: 17374006.
7. Patrizi A, Raone B, Savoia F, Bacci F, Pileri A, Gurioli C, Neri I. Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. Acta Derm Venereol. 2009;89(3):327-8. doi: 10.2340/00015555-0639. PMID: 19479145.
8. Insect Bite–like Reaction in Patients With Hematologic Malignant Neoplasms Aviv Barzilai, MD, MSc; Dorit Shpiro, MD; Iris Goldberg, PhD; et alYasmin Yacob-Hirsch, MSc; Carlos Diaz-Cascajo, MD; Dina Meytes, MD; Regina Schiby, MD; Ninette Amariglio, PhD; Henri Trau, MD. Arch Dermatol. 1999;135(12):1503-1507. doi:10.1001/archderm.135.12.1503; Indian J Dermatol Venereol Leprol. 2001 Mar-Apr;67(2):72-4.
9. Abnormal insect bite reactions: a manifestation of immunosuppression of HIV infection?K Ajithkumar 1, S George, P G Babu.] Covid-19 infection and vaccination may induce a brisk immune response that may be a hyperimmune response in some patients and has been associated with cutaneous inflammatory reactions [ Front. Immunol., 30 September 2021 Sec. Viral Immunology. https://doi.org/10.3389/fimmu.2021.742941
10. Hyperinflammatory Immune Response and COVID-19: A Double-Edged Sword Li Yin Tan1,2, Thamil Vaani Komarasamy1 and Vinod RMT Balasubramanian
11. Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment". Arch Dermatol Res. 2022 Jan;314(1):1-15. doi: 10.1007/s00403-021-02190-6. Epub 2021 Feb 9. PMID: 33559733; PMCID: PMC7871141.
12. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24. PMID: 32461193; PMCID: PMC7246018.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.